Chewing muscle thickness after radiofrequency treatment for trigeminal neuralgia
Measures masseter muscle thickness by ultrasound after nerve ganglion treatment in trigeminal neuralgia.
Key facts
- Who runs it
- Başakşehir Çam & Sakura City Hospital
- Where
- Türkiye1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Masseter Muscle Thickness in Gasser Ganglion Radiofrequency Treatment
- Status
- Recruiting
- People taking part
- 30 people, planned
- Started
- 15 Mar 2024
- Planned end
- 15 Oct 2025
- Type of study
- Interventional
- Treatments tested
- Gasserian Ganglion Radiofrequency Thermocoagulation
- Record updated
- 5 March 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with trigeminal neuralgia (sharp nerve pain in the face) who are planning radiofrequency heat treatment of the gasserian ganglion, a nerve cluster in the head. It measures the chewing (masseter) muscle by ultrasound before and after the treatment.
- Age
- 40 Years to 85 Years
- Sex
- All
- Disease stage
- Pain that has not improved with medicines for at least 3 months.
- Earlier treatment
- Medicines must have been tried without enough pain relief for at least 3 months. People must be planning radiofrequency thermocoagulation of the gasserian ganglion.
Main reasons for not taking part
- Blood clotting disorder
- Pregnancy
- Local or whole-body infection
- Not able to attend follow-up visits regularly
- Not agreeing to the ultrasound measurements
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Pain refractory to medical therapy for at least 3 months
- Planning radiofrequency thermocoagulation of gasserian ganglion
- Accept ultrasound measurements to be performed
Who cannot take part
- Coagulation disorder
- Localized or systemic infection
- Refused to participate in the study
- Not attending follow-ups regularly
- Pregnancy
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 40 and 85 years old?
This trial is currently available in Türkiye.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Trigeminal neuralgia is common painful disorder in pain medicine clinics. Gasserian ganglion radiofrequency thermocoagulation is one of the treatment option in patients with trigeminal neuralgia in refractory cases. The most commonly involved branch in trigeminal neuralgia is the mandibular branch. Masseter muscle is innervated by mandibulary nerve branch of the trigeminal nerve.
Read full original descriptionShow less
The radiofrequency thermocoagulation therapy is used to ablate the affected trigeminal nerve branch and some of patients complain of subjective masseter weakness after this procedure.
In theoretical basis, muscles innervated by target nerve are affected from ablation procedure. In this study the primary aim is to evaluate the change of the masseter muscle thickness in patients treated by gasserian ganglion radiofrequency thermocoagulation. The results may also show possible functional effect of the procedure related with masseter muscle.
The group in the trial
- Patients treated with gasserian ganglion RFT for trigeminal neuralgiaOther group
In patients who have undergone radiofrequency thermocoagulation (RFT) of the gasserian ganglion for the treatment of trigeminal neuralgia, the thickness of the masseter muscle will be measured bilaterally, free and contracted, by ultrasound on the day of the procedure (just before the procedure) and at 1 and 3 months after the procedure.
Treatment: Gasserian Ganglion Radiofrequency Thermocoagulation
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Change of the Masseter Muscle Thickness Measured by Ultrasonography After Gasser Ganglion Radiofrequency Thermocoagulation Treatment
- Plain-language title
- Chewing muscle thickness after radiofrequency treatment for trigeminal neuralgiaGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Criteria questions
- Built from NCT06278194, who can take part
- Record updated
- 5 March 2025